Genprex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was -19.50K shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 500.00 shares, a 99.57% decline year-over-year.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was -114.05K shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 500.00 shares, a 82.91% decline from fiscal 2022.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.92K shares, a 99.56% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-30 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-30 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 | |
| 2023-12-31 | -19.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 500.00 shares 10-K · filed 2025-04-01 |
| 2023-09-30 | 500.00 shares 10-Q · filed 2024-11-13 | |
| 2022-12-31 | -114.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 2.92K shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 116.97K shares 10-Q · filed 2023-11-14 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | 478.75K shares derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 670.89K shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 275.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 971.90K shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | 203.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 1.47M shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | 192.14K shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 301.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 1.28M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 769.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |